EDGAR Filing Documents for 0001628280-23-041614

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001628280-23-041614

Filing Date

2023-12-14

Accepted

2023-12-14 17:09:47

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	a2023decembers-3.htm	S-3	268513
2	EX-FILING FEES	a2023decs-3feeexhibit107.htm	EX-FILING FEES	28828
3	EX-5.1	a2023decs-3atmexhibit5.htm	EX-5.1	38871
4	EX-23.1	a2023decs-3auditorconsente.htm	EX-23.1	2519
5	GRAPHIC	image_0a.jpg	GRAPHIC	278098
	Complete submission text file	0001628280-23-041614.txt		722850

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203

Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068

CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276052 | Film No.: 231487894
SIC: 2834 Pharmaceutical Preparations